The role and therapeutic potential of prohibitin in disease.

The role and therapeutic potential of prohibitin in disease.
复制标题

DOI:
10.1016/j.bbamcr.2011.01.033
复制
发表时间:
2011-06
期刊:
Biochimica et biophysica acta
影响因子:
--
通讯作者:
Sitaraman SV
Sitaraman SV
中科院分区:
其他
文献类型:
--
作者:
Theiss AL;Sitaraman SV

文献摘要

参考文献

被引文献

相似文献

抑制素1(Prohibitin 1,PHB 1)是细胞内的一种多效性蛋白,参与细胞增殖、凋亡、转录、线粒体蛋白质折叠的调控,并作为细胞表面受体。PHB 1功能的多样性归因于所研究的细胞类型及其亚细胞定位。这篇综述讨论了最近的数据表明,不同的作用PHB 1在疾病的发病机制,并建议,针对PHB 1可能是一个潜在的治疗选择,用于治疗疾病,包括癌症,炎症性肠病,胰岛素抵抗/2型糖尿病和肥胖症。这些疾病与氧化应激增加和线粒体功能障碍有关,因此,还将讨论PHB 1在这两种反应中的作用。
Prohibitin 1 (PHB1), a pleiotropic protein in the cell, has been implicated in the regulation of proliferation, apoptosis, transcription, mitochondrial protein folding, and as a cell-surface receptor. This diverse array of functions of PHB1 is attributed to the cell type studied and its subcellular localization. This review discusses recent data that indicate a diverse role of PHB1 in disease pathogenesis and suggest that targeting PHB1 may be a potential therapeutic option for treatment of diseases including cancer, inflammatory bowel disease, insulin resistance/type 2 diabetes, and obesity. These diseases are associated with increased oxidative stress and mitochondrial dysfunction and therefore, the role of PHB1 in both responses will also be discussed.
DOI: 10.1002/pmic.200500541
发表时间: 2006-10-01
期刊: PROTEOMICS
影响因子: 3.4
作者:
Hsieh, Sen-Yung;Shih, Tsung-Chieh;Lee, Ying-Shiung
通讯作者: Lee, Ying-Shiung
DOI: 10.1016/s0960-9822(06)00261-2
发表时间: 1997-08-01
期刊: CURRENT BIOLOGY
影响因子: 9.2
作者:
Coates, PJ;Jamieson, DJ;Hall, PA
通讯作者: Hall, PA
DOI: 10.1074/jbc.m305171200
发表时间: 2003-11-28
影响因子: 4.8
作者:
Fusaro, G;Dasgupta, P;Chellappan, S
通讯作者: Chellappan, S
DOI: 10.1016/s0891-5849(98)00148-8
发表时间: 1998-12-01
影响因子: 7.4
作者:
Du, G;Mouithys-Mickalad, A;Sluse, FE
通讯作者: Sluse, FE
DOI: 10.1093/nar/14.15.6169
发表时间: 1986-08-11
影响因子: 14.9
作者:
EVELETH, DD;MARSH, JL
通讯作者: MARSH, JL